What is Global Fast-dissolving Tablets Market?
The Global Fast-dissolving Tablets Market is a rapidly growing sector in the pharmaceutical industry. These tablets are a type of drug delivery system that dissolves quickly in the mouth, without the need for water, making them particularly convenient for people who have difficulty swallowing traditional tablets or capsules. The fast-dissolving tablets are designed to disintegrate rapidly on contact with saliva, releasing the medication for quick absorption into the bloodstream. This market is driven by several factors, including the growing geriatric population, advancements in drug delivery technologies, and the increasing prevalence of chronic diseases. The convenience and ease of use of these tablets also make them popular among patients, leading to increased demand and growth in the market.
Anti-Psychotics Drug, Anti-Epileptics Drug, Other in the Global Fast-dissolving Tablets Market:
The Global Fast-dissolving Tablets Market is segmented based on the type of drugs they deliver. These include Anti-Psychotics Drugs, Anti-Epileptics Drugs, and others. Anti-Psychotics Drugs are used to treat mental health conditions such as schizophrenia and bipolar disorder. They work by altering the effects of chemicals in the brain, helping to restore balance and reduce symptoms. Anti-Epileptics Drugs are used to treat epilepsy, a neurological disorder characterized by recurrent seizures. These drugs work by reducing the abnormal electrical activity in the brain that leads to seizures. Other types of drugs delivered through fast-dissolving tablets include those for treating cardiovascular diseases, gastrointestinal disorders, and more. Each of these drug types plays a crucial role in the market, contributing to its growth and development.
CNS Diseases, Gastrointestinal Diseases, CVS Diseases, Other in the Global Fast-dissolving Tablets Market:
Fast-dissolving tablets are used in various areas of healthcare, including the treatment of CNS Diseases, Gastrointestinal Diseases, CVS Diseases, and others. In CNS Diseases, these tablets can deliver drugs that help manage conditions like Parkinson's, Alzheimer's, and multiple sclerosis. For Gastrointestinal Diseases, fast-dissolving tablets can provide quick relief from symptoms like heartburn, indigestion, and stomach ulcers. In CVS Diseases, these tablets can deliver medications that help manage conditions like hypertension, heart failure, and arrhythmias. The versatility and convenience of fast-dissolving tablets make them an ideal choice for treating a wide range of conditions, contributing to their growing popularity in the healthcare sector.
Global Fast-dissolving Tablets Market Outlook:
Looking at the market outlook, the Global Fast-dissolving Tablets Market has shown significant growth in recent years. In 2023, the market was valued at US$ 15320 million. However, it is projected to almost double in value by 2030, reaching an estimated US$ 33020 million. This represents a compound annual growth rate (CAGR) of 11.7% during the forecast period from 2024 to 2030. This substantial growth can be attributed to the increasing demand for convenient and easy-to-use drug delivery systems, advancements in pharmaceutical technology, and the growing prevalence of chronic diseases worldwide.
| Report Metric | Details |
| Report Name | Fast-dissolving Tablets Market |
| Accounted market size in 2023 | US$ 15320 million |
| Forecasted market size in 2030 | US$ 33020 million |
| CAGR | 11.7% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb, Conquer |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
